Controlled multicenter double blind trial of an oral analog of prostacyclin in the treatment of primary Raynaud's phenomenon

Journal of Rheumatology

Volumn 23, Issue 11, 1996, Pages 1917-1920

  Vayssairat, Michel ^a   Levesque, Hervé ^b   Hachulla, Eric ^c   Devulder, Bernard ^c   Malgrange, Dominique ^d   Becker, François ^e   Lorcerie, Bernard ^e   Priollet, Pascal ^f   Lazarelh, Isabelle ^f   Schmidt, Claude ^g   Baudot, Nathalie ^h   Planchen, Bernard ⁱ   Guilmot, Jean Louis ^j   Carpentier, Patrick ^k   Franco, Alain ^k   Kahan, Alain ^l  

^a HÔPITAL TENON   (France)

^b Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d SERVICE DE DERMATOLOGIE   (France)

^e HÔPITAL DU BOCAGE   (France)

^f SAINT JOSEPH HOSPITAL   (France)

^g Hôpital Nancy   (France)

^h HÔPITAL ROTHSCHILD   (France)

ⁱ HÔTEL DIEU   (France)

^j CHU BRETONNEAU   (France)

^k CHU La Tronche and University   (France)

^l Hôpital Cochin ^*  (France)

more..

Author keywords

Cold test; Prostacyclin; Raynaud's phenomenon

Indexed keywords

BERAPROST; PLACEBO; PROSTACYCLIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; COLD PRESSOR TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAYNAUD PHENOMENON;

ADMINISTRATION, ORAL; ADULT; COLD; DOUBLE-BLIND METHOD; EPOPROSTENOL; FEMALE; FINGERS; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; RAYNAUD DISEASE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0029908392     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Belch JJ, Drury JK, Capell H, et al: Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. Lancet 1983;1:313-5.
2. Yardumian DA, Isenberg DA, Rustin M, et al: Successful treatment of Raynaud's syndrome with iloprost, a chemically stable prostacyclin analogue. Br J Dermatol 1988;27:220-6.
3. McHugh NJ, Csuka M, Watson H, et al: Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. Ann Rheum Dis 1988;47:43-7.
4. Rademaker M, Cooke ED, Almond NE, et al: Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: A double blind randomised study. BMJ 1989;298:561-4.
5. Torley HI, Madhok R, Capell HA, et al: A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective disease. Ann Rheum Dis 1991;50:800-4.
6. Priollet P, Vayssairat M, Housset E: How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases. Am J Med 1987;83:494-8.
7. Vayssairat M, Evenou P, Baudot N, Priollet P, Gilard M: A new cold test for the diagnosis of Raynaud's phenomenon. Ann Vasc Sarg 1986;1:474-8.
8. Vayssairat M, Blaison N, Baudot N, Evenou Ph, Gilard M, Mathieu JF: Action de la nifedipine sur la réaction d'hyperhémie post ischémique au froid dans le phénomène de Raynaud. J Mal Vasc 1989;14:299-302.
9. 2 derivative) in Raynaud's disease and syndrome - a double blind placebo controlled study. Jpn J Clin Exp Med 1990;67:234-42.
10. Lau CS, Belch R, Madhok R, et al: A randomized, double-blind study of cicaprost, an oral prostacyclin analogue, in the treatment of Raynaud's phenomenon secondary to systemic sclerosis. Clin Exp Rheumatol 1993;11:35-40.
11. Belch JJF, Capell HA, Cooke ED, et al: Oral iloprost as a treatment for Raynaud's syndrome: A double blind multicentre placebo controlled study. Ann Rheum Dis 1995;54:197-200.
12. Mohrland JS, Porter JM, Smith EA, Belch J, Simms MH: A multiclinic, placebo-controlled, double-blind study of prostaglandin EI in Raynaud's syndrome. Ann Rheum Dis 1985;44:754-60.
13. French Cooperative Multicenter Group for Raynaud's Phenomenon: Controlled multicenter double-blind trial of nicardipine in the treatment of primary Raynaud's phenomenon. Am Heart J 1991;122:352-5.